Meridian Growth A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Meridian Growth Fund® A Class MRAGX
- NAV / 1-Day Return 28.33 / +1.36 %
- Total Assets 452.6M
-
Adj. Expense Ratio
1.230%
- Expense Ratio 1.250%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 49%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:50 AM GMT+0
Morningstar’s Analysis MRAGX
Will MRAGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
RB Global Inc | 2.55 | 14M | Industrials |
Curtiss-Wright Corp | 2.52 | 13M | Industrials |
Axogen Inc | 2.48 | 13M | Healthcare |
Federal Signal Corp | 2.41 | 13M | Industrials |
Hinge Health Inc Ordinary Shares - Class A | 2.34 | 12M | Healthcare |
Definium Therapeutics Inc Ordinary Shares | 2.25 | 12M | Healthcare |
Veracyte Inc | 2.18 | 12M | Healthcare |
StandardAero Inc | 2.14 | 11M | Industrials |
Turning Point Brands Inc | 2.13 | 11M | Consumer Defensive |
Generac Holdings Inc | 2.08 | 11M | Industrials |